Form 4: Guardant Health Director's RSU Vesting

Guardant Health Director Tariq Musa reported the vesting of 250 restricted stock units into common stock, increasing his direct ownership.

Summary

• Director Tariq Musa reported a transaction involving Guardant Health, Inc. common stock and restricted stock units.
• On November 15, 2025, 250 restricted stock units (RSUs) vested and converted into 250 shares of common stock.
• This transaction was made pursuant to a Rule 10b5-1 plan, indicating a pre-scheduled event.
• Following the transaction, Musa Tariq directly beneficially owns 7,975 shares of common stock and 3,998 restricted stock units.
• The RSU award was originally granted on March 6, 2023, with 25% vesting on the one-year anniversary of March 15, 2023 (i.e., March 15, 2024), and the remaining 75% vesting monthly for the subsequent three-year period.

Sentiment

Score: 6

Explanation: The filing reports a routine, pre-scheduled vesting of restricted stock units for a director. This is a neutral event, but the increase in direct common stock ownership by an insider can be seen as a minor positive for alignment, hence a slightly positive score.

Positives

• Director Tariq Musa's direct beneficial ownership of common stock increased by 250 shares, indicating continued equity alignment with shareholders.
• The transaction is a routine vesting event, reflecting a stable and expected component of executive compensation.

Future Outlook

The filing indicates future scheduled vesting events for the remaining restricted stock units held by Director Tariq Musa, as the award vests monthly for three years following March 15, 2024.

Industry Context

This is a routine insider transaction related to equity compensation, common across publicly traded companies in the healthcare technology and diagnostics sector, reflecting standard executive incentive structures.

Stakeholder Impact

• Shareholders: The increase in director's direct common stock ownership aligns his interests further with shareholders.
• Employees: Reflects standard equity compensation practices for executives within the company.

Next Steps

• Continued monthly vesting of the remaining 3,998 restricted stock units held by Tariq Musa over the next three years, as per the original award schedule.

Key Dates

Recommendation

This Form 4 reports a routine, pre-scheduled vesting of restricted stock units for a director, which is a standard compensation event. It does not provide new information that would fundamentally alter the investment thesis for Guardant Health, Inc. The increase in insider common stock ownership is a minor positive for alignment but not significant enough to warrant a change in recommendation based solely on this filing.

Keywords

Guardant Health, GH, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Director Ownership, Equity Compensation, Tariq Musa